Hirva Mamdani
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| MOnaliZumab in Combination With durvAlumab (MEDI4736) for tRreatmenT of Small Cell Lung Cancer (NCT05903092) | Hirva Mamdani | 2023-09-26 |
Track Hirva Mamdani automatically
Every clearance here is in the API, with alerts when new ones post.